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Acute Kidney Injury

Mary Boadu, BSN, RN, CCRN
Otterbein University, Westerville, Ohio
Introduction
A myriad of medical advances has taken
effect in our lifetime, but a phenomenon
continues with the prevalence of Acute
Kidney Injury (AKI). AKI is most prevalent
in hospitalized patients in the intensive
care units. The possibility of AKI increases
by 50% with underlying conditions like
diabetes, hypertension and genetic factors
(CDC, 2020).
Furthermore, AKI is precipitated by sepsis
prognosis and may potentially advance to
chronic kidney disease(CKD), hence the
importance of identifying, managing and
treating AKI. Advanced nurse
practitioners should be privy to the most
recent information regarding
pathophysiology, treatment and continual
care for these patients.

Signs and
Symptoms
Patients in the early stage of the disease
process may not manifest any signs and
symptoms. AKI usually does not have
distinct signs and symptoms although
decreased urine output occurs in about
70% of the patients (Patschan & Müller,
2015).
Further signs and symptoms include:
•
•
•
•
•
•
•
•

Bleeding complication
Cardiac arrythmias
Diarrhea
Electrolyte imbalances
Edema
Fatigue and tiredness
Hypertension with heart failure and
pulmonary edema
Nausea and vomiting
(Patschan & Müller, 2015).

Underlying Pathophysiology
AKI is “defined as deterioration of kidney function, as reflected by a
significant increase in serum creatinine in most patients, (70%)
urine output is decreased as well” (Patschan & Müller, 2015). AKI
may present with or without kidney damage over a few hours or a
few days. Most patient susceptible to AKI include diabetic,
hypertensive and geriatric patients. (Pavkov, 2018). Following the
recommendations of the Kidney Disease Improving Global Outcome
(KDIGO). Later stages of AKI can also be diagnosed if the following
criteria are fulfilled:
•
•

serum creatinine increase of greater than on .3 mg/dl within
48 hours,
A 1.5-fold serum creatinine increase in seven days as
compared to a known or suspected baseline (Patschan &
Müller, 2015).
The most affected population is African Americans, American
Indians, and Hispanics who would eventually develop chronic
kidney disease (CKD) due to inappropriate or inadequate
treatment of underlining conditions. Prevalent in hospitalized
patients with complications from sepsis, surgery and heart
conditions (Pavkov, 2018).

Reference: SceinceDirect.com

As a student CRNA, AKI prognosis
will determine the kind of medication
patients receive during surgery. Most
medications are eliminated through the
kidneys therefore, it is pertinent know
the effects of medications administered
to these patients. Drug dozing in critically
ill patients is challenging due to altered
pharmacokinetics and
pharmacodynamics, multiple drug
interactions and limited evidence to
guide accurate prescribing puts patients
with acute kidney injury at a high risk for
under dozing or overdosing. (Ostermann
et al., 2018). To conclude, AKI is
becoming more prevalent due to various
comorbidities like hypertension and
diabetes, this article sheds more light on
the importance of early identification and
management.

More evidence suggests that underlying risk factors such as metabolic
syndrome, obesity, hypertension, diabetes and cardiovascular disease
progressively leads AKI to CKD (Rangaswamy & Sud, 2018). There are
three major causes of AKI; pre-renal, intra-renal and post-renal.
AKI is as a result of renal hypoperfusion. Rangaswamy & Sud (2018),
classify AKI into three phases, namely the developmental stage,
extension stage and resolution stage. The developmental stage can be
described as the initial insult which then compromises GFR. This phase
may not necessarily show in patients with CKD and geriatrics. The
extension phase is the evidence phases where signs and symptoms
mentioned above me prevalent. These patients may end up with CKD
or need dialysis due to disease progression. The final stage, known as
the resolution stage conglomerate the result of injury and repair
mechanism (Rangaswamy & Sud, 2018).
Patients with CKD are at increased risk for AKI due to a reduction in
glomerular filtration rate (GFR).

Additional Sources
Significance of Pathophysiology

Table adopted from: Patschan & Müller, 2015

Conclusion

AKI can have deteriorating effects on the patient, therefore is
pertinent for the advanced clinician to have an in-depth
understanding of this disease process. Understanding baseline
risk factors, renal stressor and key diagnostics for detecting AKI
can prevent further complications. Significance of AKI is
particularly important to understand in patients in the intensive
care unit (ICU) who are particularly susceptible to the
pathophysiology (Acute Kidney Injury (AKI), 2015). Studies
suggest that decreased creatinine levels and adequate urine
output leads to underestimation of severity of kidney injury.
These may not be true measures of kidney function therefore;
clinicians should be apt in monitoring susceptible patients.

Nursing Implication
Several studies strongly reiterate the fact that early detection
and management of risks of acuity in kidney injury can minimize
the reoccurrence of chronic kidney injury disease(CKD). The
emphasis of acute renal injury management and early detection
to prevent deterioration. Ostermann et al., concur the use of
medication therapy to treat AKI as unsuccessful. They also
suggest implementing continual care for patients with acute
kidney injury in the prevention of the development of chronic
kidney disease. Increasing early detection for acute kidney injury
disease will enhance better treatment options and prevent
further deterioration to chronic kidney disease in the long term.
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